INSIGHTS ON DRUG DEVELOPMENT
-
Navigating Preclinical Drug Development Challenges With Lipid-Based Formulations
Maximize the oral bioavailability of challenging small-molecule candidates and streamline the path from preclinical toxicology to clinical trials by leveraging optimized lipid-based formulations.
-
How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics
CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.
-
Building A Human-Centric Future For Biologics Development
Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.
-
Amorphous Solids: Implications For Solubility And Stability
Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era4/21/2026
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
High-Throughput Pyrogen Testing In A Multimode Microplate Reader3/20/2026
Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.
-
Facilitate Handling Of Bulk Powders With Dry Granulation8/11/2025
Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.
-
New Approach Methodologies: The Future Of Toxicology And Safety Testing6/25/2026
NAMs are transforming toxicology with human-relevant, non-animal approaches. Learn what defines a NAM, how these methods work together, and why adoption is rapidly accelerating.
-
Characterization Of Pharmaceutical Materials With Modulated DSC12/30/2024
Modulated DSC addresses challenges in pharmaceutical material characterization, enabling precise analysis of glass transitions, and overlapping transitions, enhancing insights beyond standard DSC.
DRUG DEVELOPMENT SOLUTIONS
-
Fluorescent Stereo Microscope Leica M165 FC
The Leica M165 FC fully apochromatic corrected stereo microscope with 16.5:1 zoom optics resolves structures down to 1.1 micron for detailed fluorescent imaging.
Image coding allows easy, convenient reproduction of image settings and parameters for fast, consistent, high quality observation and documentation.
TripleBeam technology dedicates a separate beam channel for fluorescence illumination to enhance image contrast, details and intensity for better performance.
-
Leica EZ
The Leica EZ4 educational stereomicroscope with 4.4:1 zoom for entry level university and college courses such as biology, anatomy and chemistry provides over 20 years of bright LED illumination which saves time and cost of replacement bulbs.
-
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
Learn how high‑potency infrastructure, strong impurity control, and scalable payload‑linker capabilities help teams manage risk, maintain purity, and advance toward clinical‑stage ADC development.
-
Explore immunoassays and LC-MS kits for over 30 clinical areas, each with detailed specifications and broad sample compatibility for precise, high-throughput biomarker analysis.